Abide Therapeutics
Latest round
- Series B
Last raised
- Feb 2014
Total raised
- $32M
Investors
- 1
About Abide Therapeutics
Based in California, US and founded in 2011, Abide Therapeutics, Inc. is a pharmaceutical research company specialising in chemo proteomics. The firm investigated the serine hydrolase superfamily for novel drug targets.
Who invested in Abide Therapeutics
1 investor across 3 rounds
See all investors in Abide Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Abide Therapeutics
Who invested in Abide Therapeutics?
Abide Therapeutics has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Abide Therapeutics raised?
Abide Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Abide Therapeutics last raise money?
Abide Therapeutics's most recent round on record is a Series B, in Feb 2014.
What does Abide Therapeutics do?
Based in California, US and founded in 2011, Abide Therapeutics, Inc.
Where is Abide Therapeutics headquartered?
Abide Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Abide Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Abide Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Abide Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.